Skip to main content
AmigoFish

Eli Lilly Chairman & CEO David Ricks discusses GLP-1's, Alzheimer's, business development and more

From BiotechTV - News · · 23 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

From the company's headquarters in Indianapolis, he describes where he thinks the obesity field could be headed in the next few years, what might be next after beta-amyloid in Alzheimer's, and how he plans to invest for the future.

Back to BiotechTV - News · Report a problem